Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer

Chin Med J (Engl). 2020 Oct 20;133(20):2495-2497. doi: 10.1097/CM9.0000000000001070.
No abstract available

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors
  • Lung Neoplasms* / drug therapy
  • Mitogen-Activated Protein Kinase Kinases / therapeutic use
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Immune Checkpoint Inhibitors
  • Protein Kinase Inhibitors
  • Mitogen-Activated Protein Kinase Kinases